Cargando…

Development and Verification of the Amino Metabolism-Related and Immune-Associated Prognosis Signature in Gliomas

Aberrant reprogramming of metabolism has been considered a hallmark in various malignant tumors. The metabolic changes of amino acid not only have dramatic effects in cancer cells but also influence their immune-microenvironment in gliomas. However, the features of the amino acid metabolism-related...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Yang, Ye, Liguo, Geng, Rongxin, Hu, Ping, Sun, Qian, Tong, Shiao, Yuan, Fanen, Chen, Qianxue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602207/ https://www.ncbi.nlm.nih.gov/pubmed/34804978 http://dx.doi.org/10.3389/fonc.2021.774332

Ejemplares similares

Development and Verification of Glutamatergic Synapse-Associated Prognosis Signature for Lower-Grade Gliomas
por: Ye, Liguo, et al.
Publicado: (2021)

Development and validation of cuproptosis-associated prognostic signatures in WHO 2/3 glioma
por: Ye, Zhang, et al.
Publicado: (2022)

FCGBP Is a Prognostic Biomarker and Associated With Immune Infiltration in Glioma
por: Yan, Tengfeng, et al.
Publicado: (2022)

Immunomodulatory Effects of Tryptophan Metabolism in the Glioma Tumor Microenvironment
por: Xu, Yang, et al.
Publicado: (2021)

FAIM2 is a potential pan-cancer biomarker for prognosis and immune infiltration
por: Cai, Jiayang, et al.
Publicado: (2022)

Immunogenic cell death-related risk signature predicts prognosis and characterizes the tumour microenvironment in lower-grade glioma
por: Cai, Jiayang, et al.
Publicado: (2022)

Circulating Tumor Cells for Glioma
por: Zhang, Huikai, et al.
Publicado: (2021)

IRF2-ferroptosis related gene is associated with prognosis and EMT in gliomas()
por: Tong, Shiao, et al.
Publicado: (2022)

Identification of differentially expressed key genes between glioblastoma and low-grade glioma by bioinformatics analysis
por: Xu, Yang, et al.
Publicado: (2019)

Tumor Immune Microenvironment Landscape in Glioma Identifies a Prognostic and Immunotherapeutic Signature
por: Zhang, Chunyu, et al.
Publicado: (2021)

Prognosis Analysis and Validation of m(6)A Signature and Tumor Immune Microenvironment in Glioma
por: Lin, Shaojian, et al.
Publicado: (2020)

Characterization of Hypoxia Signature to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Glioma Groups
por: Lin, Wanzun, et al.
Publicado: (2020)

HHLA2 is a novel prognostic predictor and potential therapeutic target in malignant glioma
por: Qi, Yangzhi, et al.
Publicado: (2019)

HHLA2 is a novel prognostic predictor and potential therapeutic target in malignant glioma
por: Qi, Yangzhi, et al.
Publicado: (2022)

An Autophagy-Related Gene Signature Associated With Clinical Prognosis and Immune Microenvironment in Gliomas
por: Xu, Yang, et al.
Publicado: (2020)

Downregulation of LUZP2 Is Correlated with Poor Prognosis of Low-Grade Glioma
por: Li, Yong, et al.
Publicado: (2020)

Identification and validation of a 17-gene signature to improve the survival prediction of gliomas
por: Tong, Shiao, et al.
Publicado: (2022)

A Novel Karyoplasmic Ratio-Based Automatic Recognition Method for Identifying Glioma Circulating Tumor Cells
por: Zhu, Xinyi, et al.
Publicado: (2022)

Alterations in Immune-Related Genes as Potential Marker of Prognosis in Breast Cancer
por: Li, Bei, et al.
Publicado: (2020)

Identification and validation of a novel prognostic signature based on mitochondria and oxidative stress related genes for glioblastoma
por: Tong, Shiao, et al.
Publicado: (2023)

Hypoxia induced ferritin light chain (FTL) promoted epithelia mesenchymal transition and chemoresistance of glioma
por: Liu, Junhui, et al.
Publicado: (2020)

Identification of an amino acid metabolism-associated gene signature predicting the prognosis and immune therapy response of clear cell renal cell carcinoma
por: Zhang, Fan, et al.
Publicado: (2022)

Identification and Verification on Prognostic Index of Lower-Grade Glioma Immune-Related LncRNAs
por: Wen, Jing, et al.
Publicado: (2020)

A novel amino acid metabolism-related gene risk signature for predicting prognosis in clear cell renal cell carcinoma
por: Su, Jiaqi, et al.
Publicado: (2022)

A Novel Four-Gene Signature Associated With Immune Checkpoint for Predicting Prognosis in Lower-Grade Glioma
por: Xiao, Youchao, et al.
Publicado: (2020)

A Focal Adhesion-Related Gene Signature Predicts Prognosis in Glioma and Correlates With Radiation Response and Immune Microenvironment
por: Li, Haonan, et al.
Publicado: (2021)

A novel 25-ferroptosis-related gene signature for the prognosis of gliomas
por: Peng, Xiaojiang, et al.
Publicado: (2023)

Identification and Verification of Immune-Related Gene Prognostic Signature Based on ssGSEA for Osteosarcoma
por: Xiao, Bo, et al.
Publicado: (2020)

A Hypoxia-Related Long Non-Coding RNAs Signature Associated With Prognosis in Lower-Grade Glioma
por: Feng, Qinglin, et al.
Publicado: (2021)

Downregulation of CYP2E1 is associated with poor prognosis and tumor progression of gliomas
por: Ye, Liguo, et al.
Publicado: (2021)

A Novel Defined Endoplasmic Reticulum Stress-Related lncRNA Signature for Prognosis Prediction and Immune Therapy in Glioma
por: Zheng, Yinfei, et al.
Publicado: (2022)

Identification of RNA: 5-Methylcytosine Methyltransferases-Related Signature for Predicting Prognosis in Glioma
por: Wang, Peng, et al.
Publicado: (2020)

Calcium-Related Gene Signatures May Predict Prognosis and Level of Immunosuppression in Gliomas
por: Liu, Peidong, et al.
Publicado: (2022)

A prognostic NAD+ metabolism-related gene signature for predicting response to immune checkpoint inhibitor in glioma
por: Jiang, Cheng, et al.
Publicado: (2023)

Identification, Verification and Pathway Enrichment Analysis of Prognosis-Related Immune Genes in Patients With Hepatocellular Carcinoma
por: Zhu, Zhipeng, et al.
Publicado: (2021)

A Novel Defined Pyroptosis-Related Gene Signature for Predicting Prognosis and Treatment of Glioma
por: Yang, Zhihao, et al.
Publicado: (2022)

A Hypoxia-Associated Prognostic Gene Signature Risk Model and Prognosis Predictors in Gliomas
por: Gao, Feng, et al.
Publicado: (2021)

Identification and verification of the temozolomide resistance feature gene DACH1 in gliomas
por: Gu, Qiang, et al.
Publicado: (2023)

Computational Recognition and Clinical Verification of TGF-β-Derived miRNA Signature With Potential Implications in Prognosis and Immunotherapy of Intrahepatic Cholangiocarcinoma
por: Liu, Zaoqu, et al.
Publicado: (2021)

Identification and experimental verification of an anoikis and immune related signature in prognosis for lung adenocarcinoma
por: Zhang, Jia-Le, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_93c3mslfcua5179cjj1na6uluc